Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria

Clinical Chemistry

Volumn 56, Issue 1, 2010, Pages 44-52

  Lenters Westra, Erna ^a,b   Slingerland, Robbert J ^a,b  

^a ISALA HOSPITAL   (Netherlands)

^b European Reference Laboratory for Glycohemoglobin   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALCULATION; POINT OF CARE TESTING; REFERENCE VALUE; ANALYTICAL EQUIPMENT; HOSPITAL INFORMATION SYSTEM; HUMAN; REPRODUCIBILITY; STANDARD;

TRIFOLIUM;

HEMOGLOBIN A, GLYCOSYLATED; HUMANS; POINT-OF-CARE SYSTEMS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS;

EID: 73449098203     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.130641     Document Type: Article

References (25)

1. International Diabetes Federation. Diabetes facts. http://www.idf.org (Accessed November 2009). This is a section on the home page.
2. Cagliero E, Levina EV, Nathan DM. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care 1999;22:1785-9.
3. Ferenczi A, Reddy K, Lorber DL. Effect of immediate haemoglobin A1c results on treatment decisions in office practice. Endocr Pract 2001;7:85-8.
4. Miller CD, Barnes CS, Phillips LS, Ziemer DC, Gallina DL, Cook CB, et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care 2003;26: 1158 - 63.
5. Greaves RF, Northfield JT, Cameron FJ. Haemoglobin A1c: evaluation of three point of care analysers for use in a paediatric diabetes clinic. Ann Clin Biochem 2005;42:124 -9.
6. Hawkins RC. Comparison of four point-of-care HbA1c analytical systems against central laboratory analysis. Singapore Med J 2003;44:8 -11.
7. NGSP. List of NGSP certified methods (updated 11/09, listed by date certified). http://www. ngsp.org/prog/methods.pdf (Accessed November 2009).
8. CLSI. Preliminary evaluation of clinical chemistry methods; approved guideline. CLSI Document EP10-A. Wayne (PA): CLSI; 1998.
9. CLSI. Evaluation of precision performance of clinical chemistry devices; approved guideline. NCCLS Document EP5-A. Wayne (PA): CLSI; 1992.
10. CLSI. Method comparison and bias estimation using patient samples; approved guideline. CLSI Document EP9-A. Wayne (PA): CLSI; 1992.
11. Little RR, Rohlfing CL, Wiedmeyer H-M, Myers GL, Sacks DB, Goldstein DE. The National Glycohemoglobin Standardization Program (NGSP): a five-year progress report. Clin Chem 2001;47: 1985-92.
12. Little RR. Glycated haemoglobin standardization. National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med 2003;41:1191-9.
13. 1c. http://www.ifcchba1c.net/ IFCC-01.asp?type=N (Accessed November 2009).
14. Chow G. Test of equality between sets of coefficients in two linear regressions. Econometrica 1960;28:591- 605.
15. NGSP. Protocol: C. standardization and certification of methods by manufacturers. http://www. ngsp.org/prog/protocol/prot.html (Accessed November 2009).
16. Rhoads DG. EP Evaluator Release 8. DG Rhoads Associates Inc. http://www.dgrhoads.com (Accessed April 2009).
17. Homes EW, Erşahin C, Augustine GJ, Charnogursky GA, Gryzbac M, Murrell JV, et al. Analytic bias among certified methods for the measurement of hemoglobin A1c, a cause for concern? Am J Clin Pathol 2008;129:540 -7.
18. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus. . N Engl J Med 1993;329:977- 86.
19. 1c analysis-precision, accuracy and standardization: Consensus statement of the Australian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of Australia (RCPA, Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA). Clin Chem Lab Med 2007;45:1083-97.
20. Westgard QC. A war of words in laboratory medicine, part iv: the quality of glycated hemoglobin (Ghb). http://www.westgard.com/essay120.htm (Accessed November 2009).
21. Shephard M. Analytical goals for point-of-care testing used for diabetes management in Australian health care settings outside the laboratory. Point Care 2006;5:177- 85.
22. Szymezak J, Leroy N, Lavalard E, Gillery P. Evaluation of the DCA Vantage analyzer for HbA1c assay. Clin Chem Lab Med 2008;46:1195- 8.
23. Roberts WL, Frank EL, Moulton L, Papadea C, Noffsinger JK, Ou CH. Effects of nine hemoglobin variants on five glycohemoglobin methods. Clin Chem 2000;46:560 -76.
24. NGSP. HbA1c test methods and hemoglobin variants (HbS, HbC, HbE and HbD traits). http://www. ngsp.org/prog/index3.html (Accessed November 2009).
25. NGSP. NGSP news. Changes to NGSP certification criteria beginning in 2010. http://www.ngsp.org/ prog/index3.html (Accessed November 2009).